Lobeline
Alternative Names: NicErase; NicErase-SLLatest Information Update: 02 Oct 2021
At a glance
- Originator Able Laboratories
- Developer Able Laboratories; Nastech Pharmaceutical Company
- Class Alkaloids; Drug withdrawal therapies; Piperidines; Smoking cessation therapies
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Smoking withdrawal
Most Recent Events
- 14 Nov 2003 Discontinued for Smoking withdrawal (Intranasal)
- 29 Dec 1998 Discontinued-III for Smoking withdrawal in European Union (Sublingual)
- 29 Dec 1998 Discontinued-III for Smoking withdrawal in USA (Sublingual)